Division of Tumor Radiotherapy
Division of Tumor Radiotherapy

The Radiation Oncology Department of SYSMH is a leading specialty in South China, distinguished by its robust technical expertise, extensive diagnostic and therapeutic scope, and comprehensive strength. With a history spanning over 70 years, it was founded in the 1950s by the renowned radiologist, Professor Xie Zhiguang, making the hospital one of the earliest in China to practice tumor radiotherapy. The department possesses unique and advanced experience in the comprehensive diagnosis and treatment of breast, head and neck, and gynecological cancers, and has conducted numerous innovative research studies. Particularly in breast cancer radiotherapy, it has achieved nationally leading and internationally first-class standards. The department was designated as a National Clinical Key Specialty by the National Health and Family Planning Commission in 2017, approved as a Guangdong Provincial High-Level Clinical Key Specialty in 2018, recognized as a Standardized Residency Training Base for Radiation Oncology in 2017, and obtained qualification for drug clinical trials in 2019.
Currently, the department operates three inpatient wards with nearly 100 beds. The department staff includes over 50 members comprising physicians, medical physicists, and technicians. Among them are 1 Chief Physician, 1 Distinguished Professor, 5 Associate Chief Physicians, 1 Associate Chief Technologist, and 5 Master's Supervisors. The department is equipped with internationally advanced radiotherapy facilities, including: 3 linear accelerators (one each of Elekta Axesse, Varian Trilogy, and Elekta Infinity), 2 simulators (one Siemens CT large-bore simulator and one conventional nuclear simulator), as well as radiotherapy planning systems such as Eclipse and Monaco, along with corresponding radiotherapy network and departmental management systems. This enables the department to perform internationally advanced radiotherapy techniques.
In terms of research, the medical team closely follows international academic frontiers, dedicates itself to diligent study, and has achieved outstanding results. Over the past five years, the department has published more than 40 SCI-indexed papers, with the highest single-article impact factor reaching 15.84. During this period, the department, as the primary responsible unit, has secured funding from multiple projects including the National Natural Science Foundation of China, the Guangdong Natural Science Foundation, and the China Postdoctoral Science Foundation. It has applied for 1 invention patent and obtained 4 utility model patents in the field of radiotherapy patient positioning technology, establishing distinct advantages and features in the areas of precision radiotherapy and cutting-edge cancer research.
Furthermore, the department has successfully organized several influential national academic conferences and training workshops on precision radiotherapy for breast cancer. It promotes standardized radiotherapy concepts and advanced techniques across Guangdong Province and nationwide and organizes multicenter clinical studies.
Looking ahead, the Yixian Radiotherapy team will continue to tackle challenges diligently, constantly enhance clinical treatment and research standards, and strive to provide the most scientific and comprehensive medical services to our patients.

More

Featured Medical Technology

The Radiation Oncology Department is equipped with internationally advanced medical linear accelerators, capable of performing precise radiotherapy for various types of tumors. In recent years, radiation oncologists have conducted extensive innovative research in the comprehensive treatment of common malignancies. This includes integrated and precision therapies for nasopharyngeal carcinoma, such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), and image-guided radiation therapy (IGRT). We also engage in radiotherapy for gliomas based on biological target volumes, concurrent chemoradiotherapy for esophageal cancer, three-dimensional conformal radiotherapy and 4D-CT studies for liver cancer, 4D conformal radiotherapy and concurrent chemoradiotherapy for lung cancer, as well as hypofractionated radiotherapy for breast cancer and clinical research on radiosensitizers.
We plan to introduce cutting-edge medical technologies, including hypofractionated intensity-modulated radiotherapy for whole breast irradiation, accelerated partial breast irradiation, axillary radiotherapy, and intensity-modulated radiotherapy for immediate or delayed implant-based breast reconstruction. Additionally, we will utilize tools such as RecurIndex to guide decisions on whether to administer regional nodal irradiation.

More

Scientific Research Results

The department currently has five master's supervisors who have mentored numerous graduates to completion. In 2017, the department was successfully designated as a standardized residency training base for radiation oncology. It is equipped with comprehensive teaching facilities, a well-structured teaching team, a robust standardized training system for residents, and a strong academic atmosphere, enabling the effective fulfillment of all training plans and teaching responsibilities.
In response to Sun Yat-sen University’s initiative to build a world-class university, our medical team closely follows international academic frontiers. We participated in compiling the Chinese Expert Consensus on Radiotherapy for Glioma and the Chinese Guidelines for Radiotherapy of Breast Cancer. Additionally, the department actively conducts scientific research on key issues such as tumor radiosensitivity and the tumor immune microenvironment. In recent years, a positive cycle has formed, yielding significant and outstanding results. Over the past five years, the department has published over 40 SCI-indexed papers, with the highest impact factor of a single paper reaching 15.84. Many of these were published in leading journals in oncology research. Furthermore, multiple papers have been published in core domestic journals such as the Chinese Medical Journal, the Chinese Journal of Radiation Oncology, and the Chinese Journal of Medical Physics. During the same period, the department, as the primary responsible unit, has secured two projects from the National Natural Science Foundation of China, two projects from the Guangdong Natural Science Foundation, and two special funding projects from the China Postdoctoral Science Foundation. Additionally, the department has applied for one invention patent and obtained four utility model patents in the field of radiotherapy patient positioning technology. This has established distinct advantages and characteristics in the areas of precision radiotherapy and cutting-edge tumor research.

More